Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,643,086
-
Share change
-
+1,181,495
-
Total reported value
-
$5,709,000
-
Price per share
-
$2.16
-
Number of holders
-
14
-
Value change
-
+$2,521,164
-
Number of buys
-
9
-
Number of sells
-
5
Institutional Holders of ONCONOVA THERAPEUTICS INC - COM NEW (ONTX) as of Q2 2017
As of 30 Jun 2017,
ONCONOVA THERAPEUTICS INC - COM NEW (ONTX) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,643,086 shares.
The largest 10 holders included
TYNDALL CAPITAL PARTNERS L P, SABBY MANAGEMENT, LLC, 683 Capital Management, LLC, Boxer Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, PANAGORA ASSET MANAGEMENT INC, BRIDGEWAY CAPITAL MANAGEMENT INC, UBS Group AG, and Hartford Financial Management Inc..
This page lists
14
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.